Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 1 EP application Henrik Skødt has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 18, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12705608

mTOR/JAK INHIBITOR COMBINATION THERAPY

IPC classification:
A61K 31/436, A61K 31/519, A61P 35/00
Applicant:
Novartis Pharma AG
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
The patent has been granted

Please Sign in to use this feature